Inhaler
Latest AstraZeneca AB Patents:
- Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer
- Combination treatment by administering a recombinant apyrase protein in conjunction with a P2Yinhibitor
- Dry powder formulation for pulmonary delivery and methods of use
- POLQ inhibitors
- ORAL FORMULATION OF A THERAPEUTIC COMPOUND
FIG. 1 is a perspective view of the inhaler with the cover closed.
FIG. 2 shows a bottom elevation of the inhaler with the cover closed.
FIG. 3 shows a rear elevation of the inhaler with the cover closed.
FIG. 4 shows a top elevation of the inhaler with the cover closed.
FIG. 5 shows a side elevation of the inhaler with the cover closed.
FIG. 6 shows a front elevation of the inhaler with the cover closed.
FIG. 7 shows a perspective view of the inhaler with the cover open.
FIG. 8 shows a front elevation of the inhaler with the cover open.
FIG. 9 shows a side elevation of the inhaler with the cover open.
FIG. 10 shows a bottom elevation of the inhaler with the cover open.
FIG. 11 shows a top elevation of the inhaler with the cover open; and,
FIG. 12 shows a rear elevation of the inhaler with the cover open.
Claims
The ornamental design for an inhaler, as shown and described.
Type: Grant
Filed: Sep 25, 2000
Date of Patent: Oct 23, 2001
Assignee: AstraZeneca AB
Inventors: Søren Christrup (Struer), Anders Geert-Jensen (Höjberg), Mikal Jørgensen (Århus), Jørgen Rasmussen (Struer), Hugo Dines Schmidt (Århus)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Nixon & Vanderhye
Application Number: 29/130,006
International Classification: 2902;
